Era Health LLC

Era Health LLC, doing business as Veteran's Health through its Veteran's Health Medical Supply Division, supplies prosthetics, implants, surgical devices, and medical consumables to the Department of Veterans Affairs and Defense Logistics Agency as a prime contractor under a small disadvantaged business designation. The company operates primarily through a single-award $80 million Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract (SPE2DE, effective through June 2, 2030) designated as a total small business set-aside, which provides access to the DLA Electronic Catalog for ordering prosthetic implants, vascular devices, orthopedic components, surgical instruments, catheters, stents, biological grafts, and ophthalmic supplies.

Era Health is a Fort Worth, Texas-based limited liability company and small disadvantaged business with a federal contract footprint characterized by extremely high transactional volume across specialized medical device categories. The vendor's award profile comprises 18,425 total federal awards (99.6% prime, 0.4% sub) with combined potential value of $3.13 billion across the past five-plus years. Recent activity shows 721 awards in 2026 (as of mid-July), 2,347 in 2025, and 2,662 in 2024, indicating sustained but slightly declining order volume year over year. Obligated dollars total $219.9 million, representing 7% of combined potential value—a signature profile for a high-transaction-count, low-dollar-per-order vehicle participant. The vendor competes predominantly under the total small business set-aside category across its prime work; purchase orders and delivery orders typically carry no separate set-aside designations but flow through the parent DLA and VA vehicles, which themselves carry the small business restriction.

Customer concentration is extreme and anchored by the Defense Logistics Agency Troop Support Medical organization. DLA Medical Supply Chain accounts for 11,147 awards (60% of total award count) with $509.1 million combined potential value (16% of combined portfolio value), driven almost entirely by the single $80 million IDC. The Department of Veterans Affairs Veterans Health Administration represents the second major customer tier, with five high-volume VISNs (Veterans Integrated Service Network 10, 21, 2, 17, and 12) collectively representing approximately 3,577 awards and $80.7 million combined potential value. The concentration is so pronounced that 74% of all awards flow from these six customer segments, with DLA Medical Supply alone accounting for 60% of transaction count.

Era Health's parent vehicle footprint reflects the DLA-VA axis. The primary vehicle—the $80 million DLA SPE2DE20D7037 Indefinite Delivery Contract—generated 6,168 task orders valued at $34.4 million. A second DLA IDC (SPE2DE22DA019) produced 1,927 task orders worth $12.1 million. The GSA Schedule Medical Equipment and Supplies (FSS-65-II-A) carries 1,460 task orders valued at $30.4 million, positioning it as Era Health's second-largest delivery mechanism. Two additional DLA IDCs (SPE2DE25DA006 and SPE2DH20D0032) together represent 1,786 task orders and $11.1 million. The overwhelming majority of recent work originates from DLA's electronic catalog ordering process, with individual purchase orders and delivery orders typically ranging from sub-$1,000 to $100,000+ per order depending on implant or device complexity.

Award coding reflects Era Health's core capability. Top NAICS classifications are Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (9,022 awards) and Surgical Appliance and Supplies Manufacturing (6,112 awards). Top PSC codes are Laboratory Equipment and Supplies (9,356 awards) and Medical and Surgical Instruments, Equipment, and Supplies (7,488 awards). Product line diversity includes vascular implants (Viabahn stents, endografts, catheters), cardiac devices (Cardioform septal occluders, nerve stimulation systems), orthopedic implants (femoral condyles, blade plates, conical cups, cannulated screws), ophthalmic supplies (intraocular lenses, surgical instruments), surgical packs and sets, tissue grafts, and basic care consumables. Representative delivery orders include $87,615 for a Broken & Stripped Screw Removal System, $48,727 for graft stent supplies, $108,161 for surgical implants across a twelve-month VISN 20 vehicle, and recurring $3,650–$22,050 orders for Viabahn endoprosthesis variants.

Recompete exposure in the next twenty-four months is minimal: only fourteen awards with combined potential value of $635,000 face completion inside that window. The single material recompete risk is continuation or rebid of the $80 million DLA SPE2DE20D7037 contract, which expires June 2, 2030; however, that vehicle's June 2025 award date means the recompete window lies well beyond the next two years. Subcontract activity is negligible at 0.4% of total awards, with two named subs on record—Cardinal Health 200 as a prime on a December 2025 stent order and an unnamed prime on a January 2026 RF probe order—indicating Era Health operates almost exclusively as a prime and rarely engages sub relationships.